BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Bordeaux Institute of Oncology - ECPv6.17.3.1//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Bordeaux Institute of Oncology
X-ORIGINAL-URL:https://www.bricbordeaux.com/en/
X-WR-CALDESC:Events for Bordeaux Institute of Oncology
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:Europe/Paris
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20210328T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20211031T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20220327T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20221030T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20230326T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20231029T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20240331T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20241027T010000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=Europe/Paris:20220929T133000
DTEND;TZID=Europe/Paris:20220930T190000
DTSTAMP:20220901T132015Z
CREATED:20220616T110326Z
LAST-MODIFIED:20220901T132015Z
UID:19939-1664458200-1664564400@www.bricbordeaux.com
SUMMARY:Kick off meeting BRIC
DESCRIPTION:We are pleased to announce that on September 29-30\, we will be holding the first conference of our new institute\, the BRIC Kick-off meeting. \nThis first event is intended to celebrate the creation of the BRIC and to initiate a series of future symposiums and other congresses within the BRIC. \nThis kick-off meeting will be organized over a day and a half and will include the presentation of the scientific projects of the BRIC members but also of 4 renowned guests: 3 people from SAB Jean-Ehrland Ricci (C3M\, Université Côte d’Azur\, France)\, Ruth Scherz-­Shouval (Weizmann institute of Science\, Israel)\, Urszula Hibner (IGMM\, France) and Phil Jones (The Wellcome Sanger Institute\, Royaume Uni). Finally\, the second day will close with a round table discussion between patient associations and researchers on the theme of patient/researcher collaboration. \n11 sessions are reserved for presentations by BRIC researchers. We already invite each of the team leaders to communicate to us the person who will represent their team during this meeting via this internal link. Presentations by young researchers are welcome. \nA link has been sent to you by email to register for this meeting. Registration is free but mandatory. You also have the possibility to propose abstracts for the poster presentations. The final program will be communicated to you later. \nThe kick off will take place at the Institute of Optics in Talence\, building “Institut d’Optique d’Aquitaine” on line B of the streetcar\, between the stops “Arts et Métiers” and “François Bordes”. \n  \nWe look forward to seeing you at this event! \nOrganizing Committee:\nMonica Arnedos\, Marion Bouchecareilh\, Lucie Brisson\, Vanessa Desplat\, Sandrine Hamon\, Amelie Guitart\, Sarah Lesjean and Catherine Sawai
URL:https://www.bricbordeaux.com/en/event/kick-off-meeting-bric/
LOCATION:Institut d’Optique\, 1 Rue François Mitterrand\, Talence\, 33400\, France
CATEGORIES:Meetings,Scientific seminars
ATTACH;FMTTYPE=image/jpeg:https://cdn-bricbordeaux.onlc.eu/wp-content/uploads/2022/06/flyer-kick-off-meeting-v2022-07-19.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20221004
DTEND;VALUE=DATE:20221008
DTSTAMP:20220616T103006Z
CREATED:20220422T171805Z
LAST-MODIFIED:20220616T103006Z
UID:18522-1664841600-1665187199@www.bricbordeaux.com
SUMMARY:8th Meeting of The Invadosome Consortium
DESCRIPTION:Violaine Moreau and Frederic Saltel (team 3) are part of the organizing committee. \n“Pushing the frontiers of cell adhesion and migration”\nOutstanding invited speakers\, great opportunities for young scientists for talks and travel grants.\nSessions : \n\nDiversity of invadosome functions\nRegulation of invasion by chemical microenvironment\nCancer & Invasion\nImmune system\nMechanobiology\nAdvanced imaging of invadosomes\n\nEARLY BIRD Registration rates until June 15\, 2022. \nDownload the poster
URL:https://www.bricbordeaux.com/en/event/8th-meeting-of-the-invadosome-consortium/
LOCATION:Sète\, France\, Sète\, 34200\, France
CATEGORIES:Meetings
ATTACH;FMTTYPE=image/jpeg:https://cdn-bricbordeaux.onlc.eu/wp-content/uploads/2022/04/the-invadosome-consortium.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20221014
DTEND;VALUE=DATE:20221015
DTSTAMP:20221021T100550Z
CREATED:20221021T095937Z
LAST-MODIFIED:20221021T100550Z
UID:36063-1665705600-1665791999@www.bricbordeaux.com
SUMMARY:Round table collaboration between patients and researchers
DESCRIPTION:On the occasion of its launch\, the Bordeaux Institute of Oncology (BRIC) organized\, following a series of conferences\, a round table for the general public where patient associations and researchers discussed the importance of their collaboration. \nThis cooperation allows patients to better understand how donations are used\, what the research protocols are\, how to decipher the results obtained\, what happens to biopsies for which they have given their consent\, etc.\nThis collaboration has led to the emergence of the notion of the patient as partner and allows researchers\, through the proximity thus created with patients\, to humanize their daily work by making the scope of their discoveries more tangible. \nhttps://www.canal-u.tv/chaines/univ-bordeaux/collaboration-patientschercheurs \nThe round table is moderated by Yoann Frontout\, science journalist\, with the participation of : \n >> Sophie North Chassande\, teacher-researcher\, University of Bordeaux  \n >> Philippe Souque\, scientific mediator  \n >> Cyril Sarrauste\, co-responsible for the association Mon réseau Cancer Colorectal  \n >> Frédéric Saltel\, Director of Research INSERM\, Director of BRIC  \n >> Christophe Grosset\, INSERM research director\, miRCaDe
URL:https://www.bricbordeaux.com/en/event/round-table-collaboration-between-patients-and-researchers/
CATEGORIES:News
ATTACH;FMTTYPE=image/png:https://cdn-bricbordeaux.onlc.eu/wp-content/uploads/2022/10/image-table-ronde.png
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20221025
DTEND;VALUE=DATE:20221026
DTSTAMP:20221214T151625Z
CREATED:20221214T150639Z
LAST-MODIFIED:20221214T151625Z
UID:42262-1666656000-1666742399@www.bricbordeaux.com
SUMMARY:Francis Mégraud European Academy of sciences member
DESCRIPTION:Francis Mégraud\, Emeritus Professor Emérite\, team 4 “Helicobacter-associated digestive cancers\, cancer stem cells and therapeutic strategies” has been invited to join the European Academy of sciences – – Life Sciences section\n(Academia Europaea – Section Life Sciences) where it was officially introduced on October 25 in Barcelona.\nThis academy is also concerned with fields other than Life Sciences\, such as Humanities\, Social and Societal Sciences and Exact Sciences.\nIt produces reports on various topics and is called upon to provide advice to the European Union.\nThis year\, 3 Frenchmen were nominated in the Life Sciences section\, including 2 from our University\, the other being Pierre Jaïs\, Director of the IHU Liryc.
URL:https://www.bricbordeaux.com/en/event/francis-megraud-european-academy-of-sciences-member/
CATEGORIES:News
ATTACH;FMTTYPE=image/jpeg:https://cdn-bricbordeaux.onlc.eu/wp-content/uploads/2022/03/francis-megraud.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20221109
DTEND;VALUE=DATE:20221110
DTSTAMP:20230112T145342Z
CREATED:20230112T145342Z
LAST-MODIFIED:20230112T145342Z
UID:42398-1667952000-1668038399@www.bricbordeaux.com
SUMMARY:Financing of the LILOK project
DESCRIPTION:Allocation of a €500\,000 grant from the New Aquitaine Region to the Lilok project. \n  \nTheTeam 06 – MIRCADE\, Methods and Innovations for the Research in Pediatric Cancers.  has been involved in the LILOK (Living Lab For Kids) project since its inception and is a participant in this 5-year regionally funded project. The team is involved in the “Care and therapies” axis on the theme of “Medical Research” and “Therapies against childhood cancers”.\n \n  \nLILOK’s objective:\n \nPreserve and promote the health of children\, adolescents and youth. \nSummary of the LILOK project: \nThe first pediatric innovation laboratory in France\, LILOK (Living Lab for Kids) aims to accelerate the design and distribution of services and products dedicated to the health of children\, adolescents and young people.\nLILOK brings together players in the field of prevention\, care paths that promote well-being\, excellence in care\, scientific research\, and mental health\, while promoting a healthy and eco-responsible environment.\nLILOK intervenes from the emergence of the need to the industrialization of offers\, contributes to scientific expertise and therapeutic innovation\, transmits a culture of care\, and offers training for health professionals and families.\nIn partnership with local\, academic\, public and private institutional players\, LILOK’s ambition is to be a reference in innovation for children’s health. \nThe MIRCADE team has been part of the LILOK program from the very first day of its creation with the desire to promote and participate in interactions between economic\, academic and associative actors around the issue of childhood diseases\, and particularly pediatric cancers. \n  \nLink to the press article Sud-Ouest – 09/11 \nMore about the Lilok project at this link
URL:https://www.bricbordeaux.com/en/event/financing-of-the-lilok-project/
CATEGORIES:News
ATTACH;FMTTYPE=image/jpeg:https://cdn-bricbordeaux.onlc.eu/wp-content/uploads/2023/01/illustrartion-lilok-tiree-agglo-rochelle.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Paris:20221212T140000
DTEND;TZID=Europe/Paris:20221212T170000
DTSTAMP:20221214T151930Z
CREATED:20221202T162102Z
LAST-MODIFIED:20221214T151930Z
UID:42264-1670853600-1670864400@www.bricbordeaux.com
SUMMARY:Thesis defensis Juliette Rosier
DESCRIPTION:Thesis defenisis of Juliette Rosier supervised by Francois Moreau-Gaudry – Team 08 – Biotherapies Genetics and Oncology (BioGO) \nEvaluation du risque d’instabilité génomique induite par CRISPR-Cas9 et optimisation du système pour une édition plus sûre et efficace. \nMonday\, December 12 at 2pm in the amphitheater of the European Institute of Chemistry and Biology IECB (2\, Rue Robert Escarpit – 33607 PESSAC).
URL:https://www.bricbordeaux.com/en/event/thesis-defensis-juliette-rosier/
LOCATION:Amphithéatre de l’IECB\, 2 rue Robert Escarpit\, Pessac\, 33600\, France
CATEGORIES:Thesis defenses
ATTACH;FMTTYPE=image/jpeg:https://cdn-bricbordeaux.onlc.eu/wp-content/uploads/2022/12/juliette-rosier.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Paris:20230104T120000
DTEND;TZID=Europe/Paris:20230104T130000
DTSTAMP:20230316T165234Z
CREATED:20221214T153030Z
LAST-MODIFIED:20230316T165234Z
UID:42270-1672833600-1672837200@www.bricbordeaux.com
SUMMARY:Interdisciplinary seminar of Oncosphere - Amélie Guitart intervention
DESCRIPTION:Chloé James\, U1034 BMC\, Bordeaux and Amélie Guitart\, Team 10 – Normal and leukemic hematopoietic stem cells. will speak at the Oncosphere’s interdisciplinary seminars\, the January 4\, 2023 at 12\, in the IBGC conference room and by videoconference.
URL:https://www.bricbordeaux.com/en/event/interdisciplinary-seminar-of-oncosphere-amelie-guitart-intervention/
LOCATION:salle de conférence IBGC – Carreire\, 146 rue Leo Saignat\, Bordeaux\, 33000\, France
CATEGORIES:Meetings,Scientific seminars
ATTACH;FMTTYPE=image/png:https://cdn-bricbordeaux.onlc.eu/wp-content/uploads/2022/12/4-janvier.png
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20230110
DTEND;VALUE=DATE:20230111
DTSTAMP:20230417T132722Z
CREATED:20230307T130035Z
LAST-MODIFIED:20230417T132722Z
UID:42731-1673308800-1673395199@www.bricbordeaux.com
SUMMARY:A. Bikfalvi - Perils for Science - 10-01-2023
DESCRIPTION:Andreas Bikfalvi‘s presentation at a symposium on Dangers in Science in Authoritarian and Democratic Countries which takes place at Ben Gurion University in BeerSheva on January 10.\nThis conference is live-streamed.\nInfos at this link\nThe entire symposium is available for replay at this link.\nA. Bikfalvi article: The notion of truth in science and medicine\, why it matters and why we must defend it. At this link.
URL:https://www.bricbordeaux.com/en/event/a-bikfalvi-perils-for-science-10-01-2023/
ATTACH;FMTTYPE=image/jpeg:https://cdn-bricbordeaux.onlc.eu/wp-content/uploads/2023/01/perils-for-science.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20230112
DTEND;VALUE=DATE:20230114
DTSTAMP:20230110T104547Z
CREATED:20221214T141642Z
LAST-MODIFIED:20230110T104547Z
UID:42251-1673481600-1673654399@www.bricbordeaux.com
SUMMARY:Oncosphere International Meeting 2023
DESCRIPTION:The Oncosphere Nouvelle-Aquitaineorganizes its first major congress to promote its strengths and its regional organization in Bordeaux the 12 and 13 january 2023.   \nBased on the main values of the Oncosphere Nouvelle-Aquitaine network\, this congress will host prestigious international and local speakers during 8 scientific sessions. \nLink to the program \nAt the end of the 1st day of the meeting\, a round table open to the general publicis organized this Thursday at 6 pm. The topic “Who sets the research priorities: patients or researchers?” (in french) follows the round table that took place during our kick off meeting at the end of September. \n🎦 You can watch the replay of our round table at this link.
URL:https://www.bricbordeaux.com/en/event/oncosphere-international-meeting-2023/
CATEGORIES:Meetings
ATTACH;FMTTYPE=image/png:https://cdn-bricbordeaux.onlc.eu/wp-content/uploads/2022/12/oncosphere-international-meeting-2.png
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20230116
DTEND;VALUE=DATE:20230117
DTSTAMP:20230126T165547Z
CREATED:20230126T164520Z
LAST-MODIFIED:20230126T165547Z
UID:42481-1673827200-1673913599@www.bricbordeaux.com
SUMMARY:Oncosphere International Congress - BRIC participations
DESCRIPTION:The international congress of the Oncosphere was held on January 12 and 13\, 2023 in Bordeaux gathering more than 250 scientists around cancer research. Many scientists from our unit presented their work or participated in the moderation of the sessions. \nCongratulations to Camille Dantzer\, PhD student in team 3 who won the prize for the best flash-posters! \nhttps://oncospheremeeting.com/ \nThese two days of congress will be available soon in replay. Thanks to Oncosphere Nouvelle-Aquitaine and its supporters for the organization of this conference rich in exchanges.
URL:https://www.bricbordeaux.com/en/event/oncosphere-international-congress-bric-participations/
CATEGORIES:News
ATTACH;FMTTYPE=image/jpeg:https://cdn-bricbordeaux.onlc.eu/wp-content/uploads/2023/01/image-en-avant.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20230119
DTEND;VALUE=DATE:20230120
DTSTAMP:20230202T155034Z
CREATED:20230202T143819Z
LAST-MODIFIED:20230202T155034Z
UID:42549-1674086400-1674172799@www.bricbordeaux.com
SUMMARY:Focus of the SBM Department on Lucie Brisson and Thomas Mathivet
DESCRIPTION:In the last newsletter of the Department of Biological and Medical Sciences of the University of Bordeaux :\n👉Presentation of Lucie Brisson and Thomas Mathivet\, two Inserm CRs\, co-leaders of team 01 (Tumor and Vascular Biology Laboratory) and recently recruited in our U1312-BRIC unit
URL:https://www.bricbordeaux.com/en/event/focus-of-the-sbm-department-on-lucie-brisson-and-thomas-mathivet/
CATEGORIES:News
ATTACH;FMTTYPE=image/jpeg:https://cdn-bricbordeaux.onlc.eu/wp-content/uploads/2023/02/lucie-brisson-et-thomas-mathivet.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20230120
DTEND;VALUE=DATE:20230121
DTSTAMP:20230206T153018Z
CREATED:20230206T153018Z
LAST-MODIFIED:20230206T153018Z
UID:42584-1674172800-1674259199@www.bricbordeaux.com
SUMMARY:Figaro article - CRISPR - F. Moreau-Gaudry and A. bedel intervention
DESCRIPTION:Pr François Moreau-Gaudry and Dr Aurélie Bedel of Team 8 – Genetic Biotherapies and Oncology (BioGO)\, specialists in the study of genotoxicity induced by CRISPR-Cas9 testify in the Figaro article of 20/01/2023 on CRISPR technology.\n\n“The CRISPR revolution keeps its promises“\, headlines Le Figaro. Ten years after its discovery\, the genome editing tool has opened up exciting prospects for medicine. « The applications of CRISPR are too numerous to list extensively »\,notes American Jennifer Doudna\, a professor at the University of California\, Berkeley\, who developed the technique with Frenchwoman Emmanuelle Charpentier\, director of the Max Planck Research Center for Pathogen Science in Berlin. Jennifer Doudna publishes an article in the journal Science reviewing the last ten years of CRISPR-Cas9 technology. But as with any medical innovation\, however exciting it may be\, there are undesirable effects to be feared\, or at least monitored. This is the expertise developed by the Inserm team of Prof. François Moreau-Gaudry and Dr. Aurélie Bedel (U1312 Biotherapies of genetic diseases and cancers) at the University of Bordeaux. « Very quickly\, it was observed that CRISPR was less precise than expected: this is called the ‘off-target’ effect\, i.e. the scissors sometimes hit the wrong target or cause changes in the chromosome\,» explains Prof. Moreau-Gaudry. « This is of concern to us because these are molecular events that are found in cancer »\, explains Aurélie Bedel. This does not imply the suspension of ongoing trials\, she adds.\nExtract from the Inserm press review of 20/01\n\n\nLink to the online article.\nLink to the pdf of the article.\nBioGO team page.
URL:https://www.bricbordeaux.com/en/event/figaro-article-crispr-f-moreau-gaudry-and-a-bedel-intervention/
CATEGORIES:News
ATTACH;FMTTYPE=image/jpeg:https://cdn-bricbordeaux.onlc.eu/wp-content/uploads/2023/02/figaro-20-01-2023-crispr.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20230204
DTEND;VALUE=DATE:20230205
DTSTAMP:20230206T102044Z
CREATED:20230206T102044Z
LAST-MODIFIED:20230206T102044Z
UID:42569-1675468800-1675555199@www.bricbordeaux.com
SUMMARY:Labeling "Ligue contre le Cancer" of the team 03
DESCRIPTION:On this World Cancer Day\, we are very pleased to announce the labeling by the Ligue contre le cancer of team 03 – Liver Cancers and Tumor Invasion directed by Violaine Moreau and Frederic Saltel. \n\nThank you to the League\, donors and volunteers!
URL:https://www.bricbordeaux.com/en/event/labeling-ligue-contre-le-cancer-of-the-team-03/
CATEGORIES:News
ATTACH;FMTTYPE=image/png:https://cdn-bricbordeaux.onlc.eu/wp-content/uploads/2023/02/equipe-03--cancers-du-foie-et-invasion-tumorale.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Paris:20230214T110000
DTEND;TZID=Europe/Paris:20230214T120000
DTSTAMP:20230316T165234Z
CREATED:20230127T105407Z
LAST-MODIFIED:20230316T165234Z
UID:42490-1676372400-1676376000@www.bricbordeaux.com
SUMMARY:SBM seminar invited by A. Bikfalvi : Barak Rotblat
DESCRIPTION:Dr Barak Rotblat seminar:”How do cells survive glucose starvation” \nBarak Rotblat\, Ben Gurion University (BGU)\, Israël is invited by Andreas Bikfalvi (team 01) for a webinar on February 14 at 11am. \nAbstract: Cells use glucose as a primary source of energy and have developed ways to detect changes in glucose levels to activate survival mechanisms. One such mechanism is the inhibition of a protein called mTOR\, which is responsible for controlling cell growth. It was previously thought that this inhibition leads to a reduction in protein synthesis and preservation of ATP\, but our research has found that the true mechanism is actually a decrease in the translation of mRNA that codes for ACC1\, an enzyme involved in fatty acid synthesis. This leads to a decrease in fatty acid synthesis\, NADPH consumption\, and ROS levels. This mechanism is conserved in human. mouse and yeast cells and exploited by tumor cells to generate tumors in the brain\, a low-glucose environment. \nProf. Rotblat studies the molecular biology of cancer by examining the role of long non-coding RNAs and regulators of mRNA translation. Among other functions\, long non-coding RNAs (lncRNA) control regulation in cells. Protein content analysis shows that a cancerous cell is very similar to a normal cell from the same tissue; for example\, a cancerous breast cell is more similar to a breast cell than to a cancerous cell in the lung. However\, while the protein profiles of healthy and cancerous cells from a given tissue are very similar\, their lncRNA content is very different. Therefore\, lncRNA represents a promising drug and therapeutic target. Regulating mRNA translation is key in the cellular mechanism by which tumor cells adapt to stress. Prof. Rotblat and his colleagues seek drug targets and inhibitor molecules aimed at processes that are used by cancer cells to adapt to starvation conditions\, such as found in a tumor. \nZoom ID 873 524 180 13
URL:https://www.bricbordeaux.com/en/event/sbm-seminar-invited-by-a-bikfalvi-barak-rotblat/
LOCATION:visio
CATEGORIES:Meetings,Scientific seminars
ATTACH;FMTTYPE=image/jpeg:https://cdn-bricbordeaux.onlc.eu/wp-content/uploads/2023/01/seminaire-b.-rotblat.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20230215
DTEND;VALUE=DATE:20230216
DTSTAMP:20230217T154530Z
CREATED:20230217T154530Z
LAST-MODIFIED:20230217T154530Z
UID:42650-1676419200-1676505599@www.bricbordeaux.com
SUMMARY:International Childhood Cancer Day - Christophe Grosset at the National Assembly
DESCRIPTION:On the occasion of the international day of fight against childhood cancers\, the Federation Grandir Sans Cancer\, Mrs. Béatrice DESCAMPS (Deputy of the North) and Mr. Paul CHRISTOPHE (Deputy of the North) organized on Wednesday\, February 15\, 2023 at the National Assembly a lunch of exchanges dedicated to this subject. This event brought together MPs\, associations\, parents\, researchers and professionals (doctors\, social workers\, teachers…) involved in this fight for the lives of children. Christophe Grosset\, head of team 6 MIRCADE (Methods and Innovations for Research on Childhood Cancers) was present to represent the research and\, in particular\, to discuss the subject of the valorization of academic research in pediatric oncology through the BPI-France structure. \nWithin the framework of the International Childhood Cancer Day\, the MIRCADE team opens the doors of its laboratory on 22/02. Information at this link
URL:https://www.bricbordeaux.com/en/event/international-childhood-cancer-day-christophe-grosset-at-the-national-assembly/
CATEGORIES:News
ATTACH;FMTTYPE=image/jpeg:https://cdn-bricbordeaux.onlc.eu/wp-content/uploads/2023/02/assemblee-nationale.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Paris:20230222T133000
DTEND;TZID=Europe/Paris:20230222T160000
DTSTAMP:20230201T114308Z
CREATED:20230201T114308Z
LAST-MODIFIED:20230201T114308Z
UID:42539-1677072600-1677081600@www.bricbordeaux.com
SUMMARY:MIRCADE Laboratory Open House
DESCRIPTION:The team 06 – MIRCADE\, Methods and Innovations for the Research in Pediatric Cancers. opens its laboratory to the public on Wednesday 22 February in the afternoon as part of the International Childhood Cancer Day.\nThe discussions can also be followed remotely by videoconference. \nContact : christophe.grosset@inserm.fr ; Tél: 05 57 57 46 30 \nID zoom meeting : 868 9611 9718 / secret code : 666486. zoom link
URL:https://www.bricbordeaux.com/en/event/mircade-laboratory-open-house/
LOCATION:site Carreire Université de Bordeaux\, 146 rue Leo Saignat\, Bordeaux\, 33076\, France
ATTACH;FMTTYPE=image/jpeg:https://cdn-bricbordeaux.onlc.eu/wp-content/uploads/2023/02/portes-ouvertes-mircade-1.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Paris:20230228T140000
DTEND;TZID=Europe/Paris:20230228T150000
DTSTAMP:20230316T165234Z
CREATED:20230127T110636Z
LAST-MODIFIED:20230316T165234Z
UID:42496-1677592800-1677596400@www.bricbordeaux.com
SUMMARY:SBM seminar invited by M. Khatib : Robert Bristow
DESCRIPTION:Séminaire de Robert Bristow : “Evolutionary Trajectory of Aggressive Prostate Cancer: Composite Role of Genomics and Microenvironment” \nRobert Bristow\, Manchester Cancer Research Centre\, will speak on February 28 at 2:00 p.m. in the IBGC conference room\, invited by Majid Khatib (team 2). \n\nRobert Bristow is the Director of Manchester Cancer Research Centre and Director of CRUK Major Centre. He was previously a Clinician-Scientist and Professor within the Departments of Radiation Oncology and Medical Biophysics at the University of Toronto and a Senior Scientist at the Princess Margaret Cancer Centre. His primary research interests are in tumour hypoxia\, DNA damage signalling and DNA repair in tumours\, and the genomics of prostate cancer progression and cancer treatment response. He is particularly interested in novel clinical trials that intensify cancer therapy to prostate cancer patients whose tumours harbour aggressive genetic changes and hypoxic sub-regions. He has over 300 published papers and book chapters. He is twice a Canadian Foundation for Innovation (CFI) awardee. He was made a Canadian Cancer Society Research Scientist in 2004\, an ESTRO Honorary Fellow in 2011 and a Fellow of the Academy of Medical Sciences in 2019. \nNat Commun. 2021 Nov 25;12(1):6893. doi: 10.1038/s41467-021-27223-6.\nNat Commun. 2021 Oct 29;12(1):6248. doi: 10.1038/s41467-021-26489-0.\nCancer Res. 2021 Dec 1;81(23):5833-5848. doi: 10.1158/0008-5472.CAN-21-2056. Epub 2021 Oct 12.\nLancet. 2021 Sep 18;398(10305):1075-1090. doi: 10.1016/S0140-6736(21)00950-8. Epub 2021 Aug 6
URL:https://www.bricbordeaux.com/en/event/sbm-seminar-invited-by-m-khatib-robert-bristow/
LOCATION:salle de conférence IBGC – Carreire\, 146 rue Leo Saignat\, Bordeaux\, 33000\, France
CATEGORIES:Meetings,Scientific seminars
ATTACH;FMTTYPE=image/jpeg:https://cdn-bricbordeaux.onlc.eu/wp-content/uploads/2023/01/semainire-sbm-r.-bristow.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20230318
DTEND;VALUE=DATE:20230319
DTSTAMP:20230327T141645Z
CREATED:20230327T141645Z
LAST-MODIFIED:20230327T141645Z
UID:42833-1679097600-1679183999@www.bricbordeaux.com
SUMMARY:Links between vaccines and cancer: "We\, oncologists\, refute this theory".
DESCRIPTION:A collective of about 50 oncologists refute claims that Covid vaccination increases the risk of developing or worsening cancer. \nPr. Jacques Robert (team 02) is one of the editors and Dr. Frederic Delom (team 02) is one of the signatories. \nTribune in l’Express to read here \nIllustration afp.com/Fred TANNEAU
URL:https://www.bricbordeaux.com/en/event/links-between-vaccines-and-cancer-we-oncologists-refute-this-theory/
CATEGORIES:News
ATTACH;FMTTYPE=image/jpeg:https://cdn-bricbordeaux.onlc.eu/wp-content/uploads/2023/03/illustration-afp-fred-tanneau-capture.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20230321
DTEND;VALUE=DATE:20230322
DTSTAMP:20230424T155224Z
CREATED:20230424T155224Z
LAST-MODIFIED:20230424T155224Z
UID:43207-1679356800-1679443199@www.bricbordeaux.com
SUMMARY:Financing of the G-Stat MIRCADE project by SATT Aquitaine
DESCRIPTION:SATT Aquitaine invests in the maturation of innovative projects from regional public research. SATT Aquitaine’s objective is to mature these inventions\, from the stage of research results to pre-industrialization (proof of concept)\, and to support them until they are brought to market. \nLead by Christophe Grosset\, Inserm research director and head of theTeam 06 – MIRCADE\, Methods and Innovations for the Research in Pediatric Cancers.\, the GSTAT project offers a new therapeutic option for the treatment of an incurable solid tumor in children\, the infiltrating glioma of the brain stem.\nThe objective of SATT Aquitaine’s €641\,000 investment is to formulate and test the drug candidate in-vitro and in-vivo using the molecules identified during the research team’s work. \nMore information at this link
URL:https://www.bricbordeaux.com/en/event/financing-of-the-g-stat-mircade-project-by-satt-aquitaine/
CATEGORIES:News
ATTACH;FMTTYPE=image/png:https://cdn-bricbordeaux.onlc.eu/wp-content/uploads/2023/04/financement-satt-mircade-1.png
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20230322
DTEND;VALUE=DATE:20230323
DTSTAMP:20230327T134251Z
CREATED:20230327T134251Z
LAST-MODIFIED:20230327T134251Z
UID:42826-1679443200-1679529599@www.bricbordeaux.com
SUMMARY:Focus on recent work on hepatoblastoma and adult liver cancer - team 03
DESCRIPTION:The Department of Biological and Medical Sciences presents a focus on the latest publication of the 03 team– Liver Cancers and Tumor Invasion. \nArticle published in JHEP Reports “Antagonism between wild-type and mutant β-catenin controls hepatoblastoma differentiation via fascin-1” \nFocus of the department to read at this link
URL:https://www.bricbordeaux.com/en/event/focus-on-recent-work-on-hepatoblastoma-and-adult-liver-cancer-team-03/
CATEGORIES:News
ATTACH;FMTTYPE=image/png:https://cdn-bricbordeaux.onlc.eu/wp-content/uploads/2023/03/illustration.png
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20230322
DTEND;VALUE=DATE:20230323
DTSTAMP:20230328T144510Z
CREATED:20230328T144510Z
LAST-MODIFIED:20230328T144510Z
UID:42854-1679443200-1679529599@www.bricbordeaux.com
SUMMARY:Role of mitochondria in tumors - Quote from C. Grosset in Science et Médecine - Le monde
DESCRIPTION:Christophe Grosset was interviewed by Florence Rosier\, Journalist in the newspaper Le Monde\, about an American study on the spatial mapping of the mitochondrial network and the bioenergetic activity of tumor cells in lung cancer. This work\, which follows that of Christophe Grosset\, in the journal Communications Biology of December 2021\, opens the way to the study of the 3D architecture of tumor tissues and to a better understanding of its role in the development of tumor tissues and resistance to treatment. \nThe article can be found on page 2 of “Science et Médecine – Le Monde” of March 22\, 2023
URL:https://www.bricbordeaux.com/en/event/role-of-mitochondria-in-tumors-quote-from-c-grosset-in-science-et-medecine-le-monde/
CATEGORIES:News
ATTACH;FMTTYPE=image/jpeg:https://cdn-bricbordeaux.onlc.eu/wp-content/uploads/2023/03/illustration-1.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Paris:20230323T140000
DTEND;TZID=Europe/Paris:20230323T170000
DTSTAMP:20230327T134655Z
CREATED:20230327T134655Z
LAST-MODIFIED:20230327T134655Z
UID:42827-1679580000-1679590800@www.bricbordeaux.com
SUMMARY:Thesis defensis Charles Dupin
DESCRIPTION:Charles Dupin\, clinician Team 08 – Biotherapies Genetics and Oncology (BioGO) will defend his thesis on Thursday\, March 23\, 2023 at 2pm. \n“Radiosensitization of glioblastoma by an excess of porphyrins“\, carried out under the direction of Professor Sandrine Dabernat\, in the INSERM 1312 – Bordeaux Institute in Oncology unit. \nin the amphitheatre of the ENSTBB (Carreire site\, the giant blue ball next to the CROUS) \nIn remote\, zoom link sent on request.
URL:https://www.bricbordeaux.com/en/event/thesis-defensis-charles-dupin/
CATEGORIES:Meetings,Scientific seminars,Thesis defenses
ATTACH;FMTTYPE=image/png:https://cdn-bricbordeaux.onlc.eu/wp-content/uploads/2023/03/soutenance-de-these.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Paris:20230331T130000
DTEND;TZID=Europe/Paris:20230331T140000
DTSTAMP:20230327T154315Z
CREATED:20230327T154315Z
LAST-MODIFIED:20230327T154315Z
UID:42843-1680267600-1680271200@www.bricbordeaux.com
SUMMARY:monthly thematic seminar of the Macrophage Clubs - François Canonne-Hergaux & Aksam Merched - Ferroptosis
DESCRIPTION:François Canonne-Hergaux and Aksam Merched (team 06 MIRCADE – Methods and Innovations for the Research in Pediatric Cancers.) will talk about ferroptosis with a focus on iron metabolism in the macrophage but also on lipids and their oxidation in the context of liver cancer. \nFor more information (zoom link): \n\n            https://www.toclose2me.com/368822-macrophages-clubs
URL:https://www.bricbordeaux.com/en/event/monthly-thematic-seminar-of-the-macrophage-clubs-francois-canonne-hergaux-aksam-merched-ferroptosis/
LOCATION:visio
CATEGORIES:Meetings
ATTACH;FMTTYPE=image/jpeg:https://cdn-bricbordeaux.onlc.eu/wp-content/uploads/2023/03/illustration.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20230415
DTEND;VALUE=DATE:20230416
DTSTAMP:20230426T084148Z
CREATED:20230426T084148Z
LAST-MODIFIED:20230426T084148Z
UID:43226-1681516800-1681603199@www.bricbordeaux.com
SUMMARY:Samuel Amintas\, thesis prize asso NMS
DESCRIPTION:Dr Samuel Amintas\, university hospital practitioner (Bordeaux University Hospital)\, team 8 Biotherapies Genetics and Oncology BioGO\, was awarded the thesis prize of the Nutrition Méditerranée Santé (NMS) association headed by Professor Emeritus Norbert Latruffe\, during its General Assembly on April 15. \nHis thesis\, defended in June 2022\, had for subject: Radiosensitization of digestive tumors by bioactive food molecules.
URL:https://www.bricbordeaux.com/en/event/samuel-amintas-thesis-prize-asso-nms/
ATTACH;FMTTYPE=image/png:https://cdn-bricbordeaux.onlc.eu/wp-content/uploads/2023/04/prix-de-these-samuel-amintas.png
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20230426
DTEND;VALUE=DATE:20230427
DTSTAMP:20230428T082910Z
CREATED:20230426T082749Z
LAST-MODIFIED:20230428T082910Z
UID:43220-1682467200-1682553599@www.bricbordeaux.com
SUMMARY:Financing of the PORPHYRIA project by SATT Aquitaine
DESCRIPTION:SATT Aquitaine invests in the maturation of innovative projects from regional public research. SATT Aquitaine’s objective is to mature these inventions\, from the stage of research results to pre-industrialization (proof of concept)\, and to support them until they are brought to market. \nHead by Pr Emmanuel RICHARD\, PU-PH\, head of the biochemistry department at Bordeaux University Hospital and member of theteam 08 – Biotherapies Genetics and Oncology (BioGO)in collaboration with Dr Oscar MILLET of the CICBioGUNE \, Bilbao\, the project PORPHYRIA aims to develop a pharmacological therapeutic option for erythropoietic porphyrias\, a group of rare diseases of heme metabolism. The objective of the €568\,000 investment by SATT Aquitaine is to identify and validate in-vitro and in-vivo a pharmacological inhibitor of the ALAS2 enzyme\, previously identified as a therapeutic target by the BioGO team. \nMore information at this link
URL:https://www.bricbordeaux.com/en/event/financing-of-the-porphyria-project-by-satt-aquitaine/
CATEGORIES:News
ATTACH;FMTTYPE=image/png:https://cdn-bricbordeaux.onlc.eu/wp-content/uploads/2023/04/financement-satt-biogo.png
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20230511
DTEND;VALUE=DATE:20230513
DTSTAMP:20230329T091330Z
CREATED:20230329T091330Z
LAST-MODIFIED:20230329T091330Z
UID:42867-1683763200-1683935999@www.bricbordeaux.com
SUMMARY:SFC 2023 Training "Tumor heterogeneity: from DNA sequencing to clinical applications"
DESCRIPTION:Training session 2023 organized by the French Cancer Society on the theme: \n“Tumor heterogeneity: from DNA sequencing to clinical applications” which will take place on Thursday 11 & Friday 12/05/2023 at the Centre Culturel Irlandais (Paris 5e ) right next to the Institut Curie. \nThis session is organized by Pr Jacques Robert\, member of the Bric team 2\, and Frederic Saltel\, director of BRIC and co-leader of team 03 presents “Mise en évidence de l’hétérogénéité intra-tumorale par microdissection laser”. \nMore information and registration at this link \nTo join the SFC\, follow this link.
URL:https://www.bricbordeaux.com/en/event/sfc-2023-training-tumor-heterogeneity-from-dna-sequencing-to-clinical-applications/
LOCATION:Centre Culturel Irlandais\, 5 rue des Irlandais\, Paris\, 75005\, France
CATEGORIES:Meetings,Scientific seminars
ATTACH;FMTTYPE=image/jpeg:https://cdn-bricbordeaux.onlc.eu/wp-content/uploads/2023/03/illustration-2.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Paris:20230914T120000
DTEND;TZID=Europe/Paris:20230914T130000
DTSTAMP:20230811T102547Z
CREATED:20230811T102146Z
LAST-MODIFIED:20230811T102547Z
UID:44443-1694692800-1694696400@www.bricbordeaux.com
SUMMARY:Technology seminar BRIC - Mission Bio
DESCRIPTION:Our unit’s technology group invites Mission Bio. \nSingle-Cell Multi-Omics Seminar – MISSION BIO\n\n\n\nOverview of Mission Bio’s technology and offering\nExamples of applications (monitoring MRD\, resolving clonal heterogeneity\, assessing DNA methylation profile\, etc.)\nOur users’ published studies to identify tumor resistance mechanisms\, stratification of cancer patients\, etc\n\n\n\nMatteo Cattaneo\nField Application Specialist – Mission Bio\nStéphane Colinet (stephane.colinet@missionbio.com)\nSales Executive France – Mission Bio\n\nMore information at this link\n\nFlyer
URL:https://www.bricbordeaux.com/en/event/technologic-seminar-bric-mission-bio/
LOCATION:Salle de conférence BBS (Bordeaux Biologie Santé)\, 2 rue Dr Hoffmann Martinot\, Bordeaux
CATEGORIES:Meetings,Scientific seminars
ATTACH;FMTTYPE=image/jpeg:https://cdn-bricbordeaux.onlc.eu/wp-content/uploads/2023/08/missionbio-bric-technology-seminar-14-09-2023.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Paris:20230919T183000
DTEND;TZID=Europe/Paris:20230919T220000
DTSTAMP:20230804T085432Z
CREATED:20230804T085432Z
LAST-MODIFIED:20230804T085432Z
UID:44394-1695148200-1695160800@www.bricbordeaux.com
SUMMARY:Regional onco-dermatology meetings in Nouvelle-Aquitaine
DESCRIPTION:Join us on September 19 for the regional Oncodermatology meetings\, a time for exchanging useful news for your practice!\n \nThis event is organized by the dermatology department of Bordeaux University Hospital in connection with the Onco Nouvelle-Aquitaine network and with the maxillofacial surgery\, plastic surgery and radiotherapy departments of Bordeaux University Hospital and the dermatology departments of Poitiers University Hospital and Pau University Hospital. With guest of honor Pr Gaelle Quéreux from Nantes\, President of the French Dermatology Society.  \nMarie Beylot-Barry\, co-leader of Team 5 TRIO2\, is organizing the event as head of the CHU oncodermatology team\, along with its members (Anne Pham-Ledard\, Emilie Gérard\, Sorilla Mary-Prey\, Caroline Dutriaux). \nInformation and registration at this link\nRegistration is free\, but mandatory. Registration deadline: 09/15/2023
URL:https://www.bricbordeaux.com/en/event/regional-onco-dermatology-meetings-in-nouvelle-aquitaine/
LOCATION:Palais de la Bourse\, Bordeaux\, 17 place du Palais de la Bourse\, Bordeaux\, France
CATEGORIES:Meetings,Scientific seminars
ATTACH;FMTTYPE=image/jpeg:https://cdn-bricbordeaux.onlc.eu/wp-content/uploads/2023/08/rencontres-onco-dermato-na.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20230922
DTEND;VALUE=DATE:20230923
DTSTAMP:20230731T152357Z
CREATED:20230731T152357Z
LAST-MODIFIED:20230731T152357Z
UID:44329-1695340800-1695427199@www.bricbordeaux.com
SUMMARY:Microenvironment and immunotherapy of sarcomas - First edition Symposium - 22-09-2023
DESCRIPTION:As part of the RHU CONDOR (a project funded by ANR)\, the Institut Bergonié‘s coordinating team is organizing the first Immuno-oncology of Sarcomas symposium\, entitled “Microenvironment and Immunotherapy of Sarcomas”\, to be held in Bordeaux on Friday September 22\, 2023.\nThis event will bring together the international experts on the project’s Scientific Advisory Board to present the initial results obtained in the various workpackages. \nThe RHU Condor network is coordinated by Antoine Italiano\, who is also in charge of Team 9 – Sarcotarget. \nMore information at this link
URL:https://www.bricbordeaux.com/en/event/microenvironment-and-immunotherapy-of-sarcomas-first-edition-symposium-22-09-2023/
LOCATION:Palais de la Bourse\, Bordeaux\, 17 place du Palais de la Bourse\, Bordeaux\, France
CATEGORIES:Meetings,Scientific seminars
ATTACH;FMTTYPE=image/jpeg:https://cdn-bricbordeaux.onlc.eu/wp-content/uploads/2023/07/symposium-sarcoma-scaled.jpg
ORGANIZER;CN="RHU Condor":MAILTO:contact@condorprogram.com
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20230928
DTEND;VALUE=DATE:20230930
DTSTAMP:20230926T165213Z
CREATED:20230925T162117Z
LAST-MODIFIED:20230926T165213Z
UID:44558-1695859200-1696031999@www.bricbordeaux.com
SUMMARY:1st Enlight Cancer days
DESCRIPTION:Our unit is organizing the 1st meeting of the Enlight Cancer network on Thursday and Friday\, September 28-29\, 2023 \nThe Enlight network (European university Network to promote equitable quality of Life\, sustaInability and Global engagement through Higher education Transformation) is made up of European universities\, including the University of Bordeaux. Within this framework\, our unit is developing the Enlight cancer network. For these two days\, we are inviting members of 4 universities in the network: Ghent\, Galway\, Göttingen and the Basque Country\, so there will be plenty of opportunities for collaboration. \nThis event is reserved for BRIC members and invited scientists from partner universities. \nThanks to the event’s sponsors: Enlight\, Collège des écoles doctorales Université de Bordeaux\, Bristol Myers Squibb\, Casden\, Stilla\, Bordeaux Tourism & Convention. \nThis work was supported by a grant from the French government\, managed by the Agence Nationale de Recherche (ANR) as part of the future investment program\, under reference ANR-20-GURE-0006 (Action: Grandes Universités de recherche / Project acronym: ENLIGHT)\, awarded as part of the APP “Université de Bordeaux – ENLIGHT Seed-funding”. \n \n 
URL:https://www.bricbordeaux.com/en/event/1st-cancer-enlight-days/
CATEGORIES:Meetings,News
ATTACH;FMTTYPE=image/png:https://cdn-bricbordeaux.onlc.eu/wp-content/uploads/2023/09/enlight-cancerc-days-20231.png
END:VEVENT
END:VCALENDAR